Characterization of tau prion seeding activity and strains from formaldehyde-fixed tissue
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-5960
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Characterization of tau prion seeding activity and strains from formaldehyde-fixed tissue ; volume:5 ; number:1 ; day:7 ; month:6 ; year:2017 ; pages:1-12 ; date:12.2017
Acta Neuropathologica Communications ; 5, Heft 1 (7.6.2017), 1-12, 12.2017
- Schlagwort
-
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Urheber
-
Kaufman, Sarah K.
- Beteiligte Personen und Organisationen
-
Thomas, Talitha L.
Del Tredici, Kelly
Braak, Heiko
Diamond, Marc I.
SpringerLink (Online service)
- DOI
-
10.1186/s40478-017-0442-8
- URN
-
urn:nbn:de:1111-201707132267
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kaufman, Sarah K.
- Thomas, Talitha L.
- Del Tredici, Kelly
- Braak, Heiko
- Diamond, Marc I.
- SpringerLink (Online service)
Ähnliche Objekte (12)
FRET-based Tau seeding assay does not represent prion-like templated assembly of Tau filaments
Detecting Alpha Synuclein Seeding Activity in Formaldehyde-Fixed MSA Patient Tissue by PMCA
Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo
Tau seeding in cases of multiple sclerosis
Detection limitations of prion seeding activities in blood samples from patients with sporadic prion disease
Aβ43 aggregates exhibit enhanced prion-like seeding activity in mice
The cellular prion protein does not affect tau seeding and spreading of sarkosyl-insoluble fractions from Alzheimer’s disease
Decrease in Skin Prion-Seeding Activity of Prion-Infected Mice Treated with a Compound Against Human and Animal Prions: a First Possible Biomarker for Prion Therapeutics
Tau exhibits unique seeding properties in globular glial tauopathy
Heterologous cross-seeding mimics cross-species prion conversion in a yeast model
Structure of Tau filaments in Prion protein amyloidoses
Fully co-factor-free ClearTau platform produces seeding-competent Tau fibrils for reconstructing pathological Tau aggregates
FRET-based Tau seeding assay does not represent prion-like templated assembly of Tau filaments
Detecting Alpha Synuclein Seeding Activity in Formaldehyde-Fixed MSA Patient Tissue by PMCA
Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo
Tau seeding in cases of multiple sclerosis
Detection limitations of prion seeding activities in blood samples from patients with sporadic prion disease
Aβ43 aggregates exhibit enhanced prion-like seeding activity in mice
The cellular prion protein does not affect tau seeding and spreading of sarkosyl-insoluble fractions from Alzheimer’s disease
Decrease in Skin Prion-Seeding Activity of Prion-Infected Mice Treated with a Compound Against Human and Animal Prions: a First Possible Biomarker for Prion Therapeutics
Tau exhibits unique seeding properties in globular glial tauopathy
Heterologous cross-seeding mimics cross-species prion conversion in a yeast model
Structure of Tau filaments in Prion protein amyloidoses
Fully co-factor-free ClearTau platform produces seeding-competent Tau fibrils for reconstructing pathological Tau aggregates
FRET-based Tau seeding assay does not represent prion-like templated assembly of Tau filaments
Detecting Alpha Synuclein Seeding Activity in Formaldehyde-Fixed MSA Patient Tissue by PMCA
Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo
Tau seeding in cases of multiple sclerosis
Detection limitations of prion seeding activities in blood samples from patients with sporadic prion disease
Aβ43 aggregates exhibit enhanced prion-like seeding activity in mice
The cellular prion protein does not affect tau seeding and spreading of sarkosyl-insoluble fractions from Alzheimer’s disease
Decrease in Skin Prion-Seeding Activity of Prion-Infected Mice Treated with a Compound Against Human and Animal Prions: a First Possible Biomarker for Prion Therapeutics
Tau exhibits unique seeding properties in globular glial tauopathy
Heterologous cross-seeding mimics cross-species prion conversion in a yeast model
Structure of Tau filaments in Prion protein amyloidoses